As shown in Figure 5C, the percentages of CD4+CD25+Foxp3+ Treg cells infiltrated in tumor sites were dramatically decreased after WGP treatment, and were again reversed to high levels after GITR blocking treatment. The gene discussed is FOXP3; the disease is neoplasm.